1 results match your criteria: "Wilmer Eyes Institute[Affiliation]"
Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study.
Ophthalmol Glaucoma
November 2022
University of Missouri-Columbia School of Medicine, Columbia, Missouri; Department of Ophthalmology, Mason Eye Institute, University of Missouri, Columbia, Missouri; Department of Ophthalmology, Wilmer Eyes Institute, Johns Hopkins Medicine, Bethesda, Maryland. Electronic address:
Purpose: To investigate the role of netarsudil as an outcome predictor of MicroPulse transscleral laser therapy (MPTLT).
Design: Retrospective comparative study.
Subjects: Forty-seven eyes in 33 adult patients with glaucoma with a minimum of 1 month of follow-up after netarsudil treatment and 3 months of follow-up after MPTLT were included.